News
CNCR
15.16
+0.27%
0.04
Real Estate Is the Crisis Risk to Watch Now
Bloomberg · 06/21 04:00
Short-Sellers Target Biggest US Bitcoin ETF as Drawdown Deepens
Bloomberg · 05/27 12:58
SEC Planned Crackdown on ‘Misleading’ Funds Goes Far Beyond ESG
Bloomberg · 05/26 19:34
Flow Traders Executive Leaves After Swedish Ski Trip Incidents
Bloomberg · 05/10 08:00
Turn Off the Memes, This Party’s Over Like in 2000
Bloomberg · 05/10 04:54
China’s Climate-Focused Funds Surpass U.S. With $47 Billion in Assets
Bloomberg · 05/10 04:09
Cathie Wood’s Famed Market-Beating Return Is Disappearing
Bloomberg · 05/10 04:08
Biotech Fund Wipes Out Last of Its Gains Since Covid Started
Bloomberg · 05/09 20:23
BlackRock Is Killing Off Two of Its Best-Performing Mexico ETFs
Bloomberg · 05/09 17:03
Cash Is the Only Winner in a Market Gripped by Stagflation Fear
Bloomberg · 05/09 14:51
Dictator’s Son Marcos Jr. Set for Big Win in Philippine Election
Bloomberg · 05/09 13:58
Dimensional, JPMorgan Flip Billions From Mutual Funds Into ETFs
Bloomberg · 05/09 13:30
Australia’s First Crypto ETFs Expected to List This Week
Bloomberg · 05/09 12:01
Transcript: This Is What Happened to the Meme Stock Mania
Bloomberg · 04/28 19:18
Barclays Halts Sales of 30 More ETNs After Paperwork Blunder
Bloomberg · 04/28 12:33
Scaramucci’s Crypto Pivot Comes With an Eye on Tripling Assets
Bloomberg · 04/24 14:00
Wall Street Is Souring On Its Favorite Product for Rising Rates at a Pretty Weird Time
Bloomberg · 04/21 14:03
Bitcoin ETFs Set to Roll Out in Australia to Test Crypto Demand
Bloomberg · 04/20 19:00
A Bond Hedge Crushes All Rival ETFs to Post 57% Gain
Bloomberg · 04/20 13:52
Roundhill Waits Eight Months to Launch Its WEED ETF on 4/20
Bloomberg · 04/20 13:00
More
Webull provides a variety of real-time CNCR stock news. You can receive the latest news about Loncar Cancer Immunotherapy ETF through multiple platforms. This information may help you make smarter investment decisions.